F. Gantner et al., CONCANAVALIN A-INDUCED T-CELL-MEDIATED HEPATIC-INJURY IN MICE - THE ROLE OF TUMOR-NECROSIS-FACTOR, Hepatology, 21(1), 1995, pp. 190-198
Concanavalin A activates T lymphocytes in vitro and causes T-cell-depe
ndent hepatic injury in mice. T lymphocytes were previously identified
as effector cells of concanavalin A-induced liver injury. Here we rep
ort that hepatic injury is characterized by apoptotic cell death. On c
oncanavalin A challenge, the cytokines tumor necrosis factor-alpha (TN
F alpha), interleukin-2, granulocyte macrophage-colony stimulating fac
tor, and interferon-gamma were detectable in the circulation of the mi
ce. Pretreatment of mice with anti-mouse TNF-alpha antiserum protected
them from concanavalin A-induced liver injury. Nude mice failed to re
lease TNF-alpha or interleukin-2 after concanavalin A challenge and we
re protected from liver injury. Lymph node cell transfer from responde
r mice to resistant nude mice resulted in susceptibility of the latter
towards concanavalin A, i.e., to induction of cytokine release and he
patotoxicity. These experiments suggest that immunocompetent T cells p
lay a pivotal role in concanavalin A-stimulated TNF-alpha release in v
ivo. After intravenous administration of fluorescein isothiocyanate la
beled concanavalin A to mice, the most fluorescence was found within t
he liver. In vitro, concanavalin A stimulation of separate cultures of
mouse lymph node cells or nonparenchymal liver cells induced the rele
ase of minute amounts of TNF, whereas stimulation of cocultures of the
se cells resulted in production of substantial amounts of TNF-alpha. T
hese findings may explain the hepatotropic effect of concanavalin A. I
n conclusion, T-cell-dependent concanavalin A-induced apoptotic liver
injury in mice is related to immunological and cytokine-mediated disor
ders and possibly to autoreactive hepatic processes.